Biochemical and pathologic factors affecting technetium-99m-methoxyisobutylisonitrile imaging results in patients with primary hyperparathyroidism


Ozderya A., Temizkan S., Gul A. E. , Ozugur S., Cetin K. , Aydin K.

ANNALS OF NUCLEAR MEDICINE, cilt.32, sa.4, ss.250-255, 2018 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 32 Konu: 4
  • Basım Tarihi: 2018
  • Doi Numarası: 10.1007/s12149-018-1239-y
  • Dergi Adı: ANNALS OF NUCLEAR MEDICINE
  • Sayfa Sayıları: ss.250-255

Özet

Technetium 99 m methoxyisobutylisonitrile (Tc-99m MIBI) scintigraphy represents the most commonly utilized imaging modality for the detection of the diseased gland in patients with primary hyperparathyroidism (PHPT). In this study, we aimed to identify potential biological factors with an impact on MIBI sensitivity.